1092352-55-0 Usage
General Description
Tert-Butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate is a chemical compound with the molecular formula C12H15ClN4O2. It is a derivative of pyrido[4,3-d]pyrimidine and is commonly used in pharmaceutical research and drug development. tert-Butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate has been studied for its potential biological activities, including its application as an antiviral and anticancer agent. Its tert-butyl ester group and chlorine substituent make it a valuable intermediate for the synthesis of diverse bioactive compounds. Additionally, its 2-chloro group may play a crucial role in defining its chemical and biological properties. Overall, tert-Butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate has garnered significant interest in medicinal chemistry for its potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1092352-55-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,3,5 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1092352-55:
(9*1)+(8*0)+(7*9)+(6*2)+(5*3)+(4*5)+(3*2)+(2*5)+(1*5)=140
140 % 10 = 0
So 1092352-55-0 is a valid CAS Registry Number.
1092352-55-0Relevant articles and documents
NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
-
Page/Page column 86-87, (2020/01/08)
The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
GLYCOSIDASE INHIBITORS
-
Page/Page column 98-99, (2017/09/15)
Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
